CELL & GENE THERAPY
Cell and gene therapy involves modifying or harnessing cells and genetic material to treat or cure diseases at their source. We provide a wide array of high-quality reagents and tools—such as viral vectors, cytokines, and characterization assays—to support research and development in cell and gene therapy.
Gene Therapy
Our principals provide high-quality products supporting gene therapy from discovery to clinical stages, ensuring precision and reliability throughout development.
CAR-T
Allianz Bio CAR-T tools (Proteins, Abs, Magnetic Beads, Kits and Media) for targeted cancer immunotherapy, optimizing specificity and efficacy, and supporting the development and clinical translation of CAR-T therapies.
CAR-NK
Our CAR-NK solutions offer advanced engineered Natural Killer cells for targeted cancer immunotherapy, providing enhanced tumor targeting and immune activation.
TIL
Allianz Bio offers TIL solutions with high-quality expanded lymphocytes, enabling personalized cancer immunotherapy by harnessing the patient’s immune cells to target and eliminate tumors.
TCR-T
We offer high-quality reagents for TCR-T therapy development, enabling precise targeting of cancer cells through engineered T-cell receptors that recognize intracellular tumor antigens.